Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 600.70M | 526.50M | 429.80M | 256.70M | 128.40M | 94.40M |
Gross Profit | 239.50M | 172.70M | 90.20M | 28.40M | 22.90M | 20.40M |
EBITDA | -188.60M | -183.90M | -209.80M | -282.60M | -229.90M | -119.10M |
Net Income | -204.00M | -202.20M | -236.90M | -297.80M | -241.30M | -122.30M |
Balance Sheet | ||||||
Total Assets | 1.93B | 1.85B | 1.63B | 1.69B | 1.51B | 828.70M |
Cash, Cash Equivalents and Short-Term Investments | 670.30M | 1.01B | 264.50M | 1.03B | 1.07B | 577.40M |
Total Debt | 143.70M | 107.20M | 43.10M | 35.20M | 22.30M | 0.00 |
Total Liabilities | 1.41B | 1.26B | 924.40M | 823.90M | 522.30M | 287.70M |
Stockholders Equity | 527.10M | 593.40M | 708.90M | 866.80M | 988.20M | 541.00M |
Cash Flow | ||||||
Free Cash Flow | -21.40M | -20.80M | -128.30M | -173.10M | -154.00M | -96.10M |
Operating Cash Flow | -11.60M | -11.40M | -119.10M | -163.00M | -144.60M | -91.70M |
Investing Cash Flow | -62.40M | 40.60M | 88.70M | 181.10M | -804.80M | 50.10M |
Financing Cash Flow | 102.70M | 87.70M | 15.40M | 3.60M | 649.60M | 341.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.00B | 15.43 | 16.20% | ― | 22.20% | 5.78% | |
77 Outperform | $1.98B | 22.71 | 6.27% | 2.70% | 14.00% | 100.44% | |
76 Outperform | $1.08B | 12.71 | 10.08% | 5.02% | 18.52% | 65.66% | |
73 Outperform | $2.26B | 15.11 | 23.90% | 0.92% | 9.62% | -18.69% | |
68 Neutral | $18.05B | 11.73 | 10.24% | 3.73% | 9.66% | 1.70% | |
65 Neutral | $1.37B | 18.53 | 27.52% | ― | 59.76% | ― | |
55 Neutral | $3.83B | ― | -35.10% | ― | 22.91% | 4.95% |
Lemonade, Inc. announced the terms of its reinsurance program effective from July 1, 2025, to June 30, 2026, involving a reduction in the ceded proportion of its quota share reinsurance from approximately 55% to 20%. This strategic move is expected to maintain a variable ceding commission rate similar to previous agreements, potentially impacting the company’s financial strategy and stakeholder interests.
On June 4, 2025, Lemonade held its annual meeting of stockholders, with 68.41% of the voting power represented. During the meeting, Shai Wininger and Dr. Samer Haj-Yehia were elected as Class II Directors until 2028. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 was ratified, and the compensation of the company’s named executive officers was approved on a non-binding basis.